These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25154416)
1. 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. Dar A; Wu D; Lee N; Shibata E; Dutta A Mol Cell Biol; 2014 Nov; 34(21):4049-61. PubMed ID: 25154416 [TBL] [Abstract][Full Text] [Related]
2. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2. Abbas T; Keaton M; Dutta A Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434 [TBL] [Abstract][Full Text] [Related]
3. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Abbas T; Mueller AC; Shibata E; Keaton M; Rossi M; Dutta A Mol Cell; 2013 Mar; 49(6):1147-58. PubMed ID: 23478445 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase. Rossi M; Duan S; Jeong YT; Horn M; Saraf A; Florens L; Washburn MP; Antebi A; Pagano M Mol Cell; 2013 Mar; 49(6):1159-66. PubMed ID: 23478441 [TBL] [Abstract][Full Text] [Related]
5. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis. Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma. Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051 [TBL] [Abstract][Full Text] [Related]
7. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex. Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527 [TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1. Leng F; Saxena L; Hoang N; Zhang C; Lee L; Li W; Gong X; Lu F; Sun H; Zhang H J Biol Chem; 2018 Dec; 293(49):18879-18889. PubMed ID: 30301766 [TBL] [Abstract][Full Text] [Related]
9. Mutations at multiple CDK phosphorylation consensus sites on Cdt2 increase the affinity of CRL4 Nukina K; Hayashi A; Shiomi Y; Sugasawa K; Ohtsubo M; Nishitani H Genes Cells; 2018 Mar; 23(3):200-213. PubMed ID: 29424068 [TBL] [Abstract][Full Text] [Related]
16. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Kim Y; Starostina NG; Kipreos ET Genes Dev; 2008 Sep; 22(18):2507-19. PubMed ID: 18794348 [TBL] [Abstract][Full Text] [Related]
17. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471 [TBL] [Abstract][Full Text] [Related]
19. Stress-stimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor. Chandrasekaran S; Tan TX; Hall JR; Cook JG Mol Cell Biol; 2011 Nov; 31(22):4405-16. PubMed ID: 21930785 [TBL] [Abstract][Full Text] [Related]
20. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Centore RC; Havens CG; Manning AL; Li JM; Flynn RL; Tse A; Jin J; Dyson NJ; Walter JC; Zou L Mol Cell; 2010 Oct; 40(1):22-33. PubMed ID: 20932472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]